OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study
Claudia Weiß, Lena‐Luise Becker, Johannes Friese, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101092-101092
Open Access | Times Cited: 7
Claudia Weiß, Lena‐Luise Becker, Johannes Friese, et al.
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101092-101092
Open Access | Times Cited: 7
Showing 7 citing articles:
Safety of Onasemnogene Abeparvovec Administration to Type 1 SMA Patients Who Have Received Risdiplam
Sivakami Chelladurai, Sarah D’Urso, Mark Atherton, et al.
Journal of Clinical Neuromuscular Disease (2025) Vol. 26, Iss. 3, pp. 140-147
Closed Access
Sivakami Chelladurai, Sarah D’Urso, Mark Atherton, et al.
Journal of Clinical Neuromuscular Disease (2025) Vol. 26, Iss. 3, pp. 140-147
Closed Access
Real-world evidence in spinal muscular atrophy: addressing heterogeneity of populations and treatment comparisons
Juliette Ropars, Lamiae Grimaldi‐Bensouda, Susana Quijano-Roy
The Lancet Regional Health - Europe (2025) Vol. 52, pp. 101248-101248
Closed Access
Juliette Ropars, Lamiae Grimaldi‐Bensouda, Susana Quijano-Roy
The Lancet Regional Health - Europe (2025) Vol. 52, pp. 101248-101248
Closed Access
Pre‐symptomatic risdiplam treatment for spinal muscular atrophy initiated at 12 days post‐birth: 14‐month safety and developmental outcomes
Zhihao Sun, Liping Wu, Yufan Hui, et al.
Pediatric Investigation (2025)
Open Access
Zhihao Sun, Liping Wu, Yufan Hui, et al.
Pediatric Investigation (2025)
Open Access
The ABCs of neuropaediatrics
Lucia Gerstl, Florian Heinen
Developmental Medicine & Child Neurology (2025)
Closed Access
Lucia Gerstl, Florian Heinen
Developmental Medicine & Child Neurology (2025)
Closed Access
The efficacy of gene therapy with onasemnogene abeparvovec in spinal muscular atrophy in young patients
Daria A. Fisenko, А. Л. Куренков, Л. М. Кузенкова, et al.
L O Badalyan Neurological Journal (2025) Vol. 6, Iss. 1, pp. 13-25
Closed Access
Daria A. Fisenko, А. Л. Куренков, Л. М. Кузенкова, et al.
L O Badalyan Neurological Journal (2025) Vol. 6, Iss. 1, pp. 13-25
Closed Access
Spinal muscular atrophy in Brazil: from individual treatment to global management
Laurent Servais, Cristiane Araújo Martins Moreno
Jornal de Pediatria (2024) Vol. 101, Iss. 1, pp. 4-6
Open Access | Times Cited: 1
Laurent Servais, Cristiane Araújo Martins Moreno
Jornal de Pediatria (2024) Vol. 101, Iss. 1, pp. 4-6
Open Access | Times Cited: 1
Gene therapy for spinal muscular atrophy: timing is key
Laurent Servais
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101112-101112
Open Access
Laurent Servais
The Lancet Regional Health - Europe (2024) Vol. 47, pp. 101112-101112
Open Access
